Diminazene Aceturate Liposomes: Morphometric and Biochemical Liver, Kidney, and Spleen of Rats Infected with Trypanosoma evansi

Pathology Research and Practice

Volumn 210, Issue 12, 2014, Pages 840-846

  Oliveira, Camila Belmonte ^a   Rigo, Lucas Almeida ^b   França, Raqueli T ^a   Gressler, Lucas T ^a   Dalla Rosa, Luciana ^a   Ourique, Aline F ^b   Oliveira, Dionatan T ^a   Doyle, Rovaina L ^a   Moreira, Karen Luise dos Santos ^a   Veiga, Marcelo L ^a   Lopes, Sonia T A ^a   Beck, Ruy Carlos R ^b   Da Silva, Aleksandro S ^c   Monteiro, Silvia G ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c SANTA CATARINA STATE UNIVERSITY   (Brazil)

Author keywords

Diamidines; Lipid vesicles; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; CREATININE; DIMINAZENE ACETURATE; GAMMA GLUTAMYLTRANSFERASE; LIPOSOME; UREA; ANTITRYPANOSOMAL AGENT; BIOLOGICAL MARKER; DIMINAZENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; GLOMERULUS; HISTOPATHOLOGY; KIDNEY; KIDNEY FUNCTION; LIVER; LIVER CELL; LIVER FUNCTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; SPLEEN; SURRA; TRYPANOSOMA EVANSI; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; METABOLISM; PATHOGENICITY; PATHOLOGY; TIME; TRYPANOSOMA; TRYPANOSOMIASIS; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; DIMINAZENE; DISEASE MODELS, ANIMAL; KIDNEY; KIDNEY FUNCTION TESTS; LIPOSOMES; LIVER; LIVER FUNCTION TESTS; MALE; RATS, WISTAR; SPLEEN; TIME FACTORS; TRYPANOCIDAL AGENTS; TRYPANOSOMA; TRYPANOSOMIASIS;

EID: 84949114744     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.08.010     Document Type: Article

References (33)

1. Allen T.M., Martin F.J. Advantages of liposomal delivery systems for anthracyclines. Semin. Oncol. 2004, 31:5-15.
2. Aquino L.P.C.T., Machado R.Z., Alessi A.C., Santana A.E., Castro M.B., Marques L.C., Malheiros E.B. Aspectos hematológicos, bioquímicos e anatomopatológicos da infecção de Trypanosoma evansi em cães. Arquivo Brasileiro Medicina Veterinária Zootecnia 2002, 54:8-18.
3. Bloom W., Fawcett D.W. Tratado de Histologia. Interamericana 1977, 940.
4. Boyd R., Mahmoud M.M., Gray A.R. Changes in the levels of some serum enzymes in dromedary camels infected with T. evansi. Res. Vet. Sci. 1980, 28:336-340.
5. Brandão L.P., Larsoon M.H.M., Júnior E.H.B., Hagiwara M.K., Ventura R.M., Teixeira M.M.G. Infecção Natural pelo Trypanosoma evansi em cão-Relato de caso. Clín Vet 2002, 7:23-26.
6. Colpo C.B., Monteiro S.G., Stainki D.R., Colpo E.T.B., Henriques G.B. Infecção Natural por Trypanosoma evansi em cão no Rio Grande do Sul. Ciênc. Rural 2005, 35:717-719.
7. Da Silva A.S., Costa M.M., Cargnelutti J.F., Lopes S.T.A., Monteiro S.G. Alterações bioquímicas em coelhos infectados experimentalmente pelo Trypanosoma evansi. Rev. Bras. Parasitol. 2007, 16:43-46.
8. Egbe-Nwiyi T.N., Igbokwe I.O., Onyeyili P.A. Diminazene Aceturate Resistance on the Virulence of Trypanosoma brucei for Rats. J. Comp. Pathol. 2005, 133:4286-4288.
9. Eghianruwa K.I., Anika S.M. Efficacy of diminazene aceturate with and without levamisole or dimethyl sulfoxide in reducing organ weight and parasitemia in T. congolense infected rats. Int. J. Anim. Vet. Adv. 2011, 4:306-311.
10. Elamin E.A., Homeida A.M., Adam S.E., Mahmoud M.M. The efficacy of berenil (diminazene aceturate) against Trypanosoma evansi infection in mice. J. Vet. Pharmacol. Ther. 1982, 5:259-265.
11. Frézard F., Schettini D.A., Rocha O.G., Demicheli C. Lipossomas: propriedades físicas- químicas e farmacológicas aplicações na quimioterapia à base de antimónio. Quím Nova 2005, 28:511-518.
12. González F.H.D., Silva S.C. Introdução à bioquímica clínica veterinária 2006, 198. UFRGS, Porto Alegre.
13. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Ormediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes. Gene 1995, 159:167-174.
14. Guterres S.S., Müller C.R., Michalowski C.B., Pohlmann A.R., Dalla Costa T. Gastro-intestinal tolerance following oral administration of spray-dried diclofenac-loaded nanocapsules and nanospheres. STP Pharm. Sci. 2001, 11:229-233.
15. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticle for oral delivery of peptides. Is there role for polymers to affect mucosa uptake. Euro. J. Pharm. Biopharm. 2000, 50:147-160.
16. Lasic DD. Novel applications of liposomes. In: Tibtech 16, 307-320.
17. Levine N.D. Protozoan Parasites of Domestic Animals and of Man 1998, 406. Burgess, Minneapolis.
18. Losa C., Marchal-Heussler L., Orallo F., Vila Jato J.L., Alonso M.J. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm. Res. 1993, 10:80-87.
19. Losos G.J., Crockett E. Toxicity of beril in the dog. Vet. Rec. 1969, 85:196.
20. Mamot C., Drummond D.C., Hong K., Kirpotin D.B., Park J.W. Liposome-based approaches to overcome anticancer drug resistance. Drug Res. 2003, 6:271-279.
21. Meyer D.L., Coles E.H., Rich L.J. Veterinary Laboratory Medicine, Interpretation of Diagnosis 1992, 350. Saunders, Philadelphia.
22. Monzón C.M., Mancebo O.A. Diagnóstico Parasitológico de Trypanosoma equinum (Vogés 1901) en Estabelecimientos Ganaderos del Area Subtropical Argentina. Vet. Ar. 1986, 30(1986):997-999.
23. Oliveira C.B., Rigo L.A., Dalla Rosa L., Gressler L.T., Zimmermann C.E., Ourique A.F., Miletti L.C., Beck R.C.R., Monteiro S.G. Liposomes produced by reverse phase evaporation: in vitro and in vivo efficacy of diminazene aceturate against Trypanosoma evansi. Parasitology 2014, 141:761-769.
24. Onyeyili P.A., Anika S.M. Diminazene aceturate residues in the tissues of healthy, Trypanosoma congolense and Trypanosoma brucei brucei infected dogs. Braz. Vet. J. 1991, 147:155-162.
25. Peregrine A.S., Mamman M. Pharmacology of diminazene: a review. Acta Trop. 1993, 54:185-203.
26. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion E.A., Kaiser J.W. CCL2 recruits inflammatory monocytes to facilitate breast-tumor metastasis. Nature 2011, 475:222-225.
27. Gregoriadis G. Interactions of liposomes with plasma proteins. Liposome Technology 1984, 3:205-224.
28. Shimizu K., Maitani Y., Takayama K., Nagai T. Characterization of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture by differential scanning calorimetry, Fourier transform infrared spectroscopy, and enzymatic assay. J. Pharm. Sc. 1996, 85:1520-6017.
29. Silva R.A.M.S., Seidl A., Ramirez L., Dávila A.M.R. Trypanosoma evansi e Trypanosoma vivax: Biologia, Diagnóstico e controle 2002, 141. Embrapa Pantanal, Corumbá.
30. Silva A.S., Doyle R.L., Monteiro S.G. Métodos de contenção e confecção de esfregaço sanguíneo para pesquisa de hemoparasitas em ratos e camundongos. Rev Faculd Zootec Vet Agron 2006, 13:83-87.
31. Stockham S.I., Scott M.A. Fundamentos De Patologia Clínica Veterinária 2011, 720. Guanabara Koogan.
32. Tuntasuvan D., Jarabrum W., Viseshakul N., Mohkaew K., Borisutsuwan S., Theeraphan A., Kongkanjana N. Chemotherapy of surra in horses and mules with diminazene aceturate. Vet. Parasitol. 2003, 110:227-233.
33. Vail D.M., Amantea M.A., Colbern G.T., Martin F.J., Hilger R.A., Working P.T. Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin. Oncol. 2004, 31:1316-1335.